EQUIPE LABELLISEE PAR LA FRM 2020-2023- Patient-specific human induced pluripotent stem cells as a cellular platform to detect and predict anti-cancer drug-induced cardiac arrhythmias

ANR CORRECT-LMNA « Gene editing therapeutics for LMNA cardiomyopathy » 2019-2022, JS Hulot Partner

ANR PRC PACIFIC project « Pw1+ stromal cells in cardiac fibrosis » 2018-2021, JS Hulot PI

Leducq Foundation Translatlantic Networks of Excellence “Towards precision medicine with human iPSCs for cardiac channelopathies” coordinated by Prs Joseph Wu (Stanford, USA) and Peter Schwartz (Milano, IT) – 2019-2024, JS Hulot Network member

ANRT – CIFRE “Modeling cardiac relaxation using human iPSC-based engineered cardiac tissues” 2018-2021, JS Hulot PI

ANR PRC NAD-Heart “NAD+ precursor for metabolic therapy of heart failure” 2017-2020, JS Hulot partner

ANR PRC CAPTOR “Controling fate-determination of adipose-tissue derived progenitors to improve obesity-related metabolic disorders” 2017-2020, D Sassoon Partner

Era-CVD CLARIFY “Communicaition between cardiomyocytes, cardiac stem cells and innate immune cells in failing hearts” 2017-2020, JS Hulot Partner

LABEX Revive “Cellules souches et médecine régénérative” 2016-2019, D Sassoon Partner

H2020 CVENT « risk assessment of plaque rupture and future cardiovascular events by multi-spectral photoacoustic imaging” 2016-2019, P Boutouyrie Partner

H2020, CARDIS “Early Stage Cardiovascular disease detection with integrated silicon photonics”, 2015-2019, P Boutouyrie Partner